Clinical trial
Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma
NCT00475813 · Mundipharma Research Limited, Industry · Completed
Key facts
| NCT number | NCT00475813 |
|---|---|
| Title | Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma |
| Lead sponsor | Mundipharma Research Limited, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | FLUTIFORM® (Formoterol fumarate / Fluticasone propionate) |
| Enrollment | 211 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | May 21, 2007 |
| Last update posted | Oct 24, 2018 |
| Countries | Czechia, France, Germany, Hungary, Poland, Romania |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: